| Blood biomarkers for evaluation of perinatal encephalopathy: state of the art |
19 |
| Management of pediatric low-grade glioma |
16 |
| Precision medicine in pediatric oncology |
14 |
| Neonatal abstinence syndrome: an update |
14 |
| Mitochondrial disease genetics update: recent insights into the molecular diagnosis and expanding phenotype of primary mitochondrial disease |
12 |
| Obesity and chronic kidney disease |
10 |
| Applications of near infrared spectroscopy in the neonate |
9 |
| The medical home for children with autism spectrum disorder: an essential element whose time has come |
9 |
| Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis |
9 |
| Zika clinical updates: implications for pediatrics |
9 |
| Genetic characteristics of patients with congenital hyperinsulinism |
8 |
| Management of hypertonia in cerebral palsy |
8 |
| Influenza: annual seasonal severity |
8 |
| Developmental dysplasia of the hip: an update on diagnosis and management from birth to 6 months |
8 |
| Pediatric postoperative opioid prescribing and the opioid crisis |
8 |
| Is acute kidney injury a harbinger for chronic kidney disease? |
8 |
| Arguments against routine administration of probiotics for NEC prevention |
7 |
| Evolving understanding of neonatal necrotizing enterocolitis |
7 |
| Cardiovascular disease in Williams syndrome |
7 |
| Genetics of pubertal timing |
7 |
| Infantile hemangiomas: what have we learned from propranolol? |
6 |
| Review of molecular classification and treatment implications of pediatric brain tumors |
6 |
| Advances in neuroblastoma therapy |
6 |
| Air pollution, ambient temperature, green space and preterm birth |
6 |
| New age technology and social media: adolescent psychosocial implications and the need for protective measures |
6 |
| Newborn screening in the developing countries |
6 |
| The importance of the microbiome in pediatrics and pediatric infectious diseases |
6 |
| Cardiovascular disease in Down syndrome |
6 |
| Cardiovascular disease in Noonan syndrome |
6 |
| Cardiovascular disease in survivors of childhood cancer |
6 |
| Prematurity and future kidney health: the growing risk of chronic kidney disease |
6 |
| The physiology of neonatal resuscitation |
5 |
| Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry |
5 |
| The genesis of systems of care for transition to adulthood services: emerging models in primary and subspecialty care |
5 |
| Precision medicine in pediatric sepsis |
5 |
| Prevention of allergy with diverse and healthy microbiota: an update |
5 |
| Late effects of pediatric brain tumors |
5 |
| New directions in point-of-care ultrasound at the crossroads of paediatric emergency and critical care |
5 |
| Evidence supporting laparoscopic hernia repair in children |
5 |
| Retinitis pigmentosa: recent advances and future directions in diagnosis and management |
5 |
| Pediatric headache: overview |
5 |
| The growing epidemic of sexually transmitted infections in adolescents: a neglected population |
5 |
| Button battery and magnet ingestions in the pediatric patient |
5 |
| Foreign body ingestion in pediatric patients |
5 |
| The good bugs: the use of probiotics in pediatrics |
5 |
| Update in the management of acne in adolescence |
5 |
| New developments in the genetic diagnosis of short stature |
5 |
| Pediatric palliative oncology: the state of the science and art of caring for children with cancer |
5 |
| New primary immunodeficiency diseases: context and future |
5 |
| New immunodeficiency syndromes that help us understand the IFN-mediated antiviral immune response |
5 |
